Neuroscience News and Research

RSS

Certain antirheumatic drugs may lower incidence of Alzheimer's and related dementias in people with cardiovascular disease

New findings from the ongoing Drug Repurposing for Effective Alzheimer's Medicines (DREAM) study suggest that certain rheumatoid arthritis drugs may lower incidence of Alzheimer's disease and related dementias in people with cardiovascular disease.

8 Apr 2022

Mutant mice with a human gene variant exhibits ADHD-like problems

Mutant mice are providing scientists with a new neurobiological framework to understand the brain changes observed in distractible humans who carry a common gene variant whose frequency has been associated with Attention Deficit Hyperactivity Disorder (ADHD).

7 Apr 2022

Axol Bioscience Raises £3.2 Million GBP (c. $4.2 million USD)

Axol Bioscience Ltd. today announced that it has raised £3.2 million GBP in the extension of its previous funding round, bringing the total raised to £7 million GBP.

From Axol Bioscience Ltd 7 Apr 2022

People with some types of epilepsy may have a lower quality of life, study suggests

A new study suggests that people with epilepsy associated with head injuries, especially the type not well controlled by medication, are more likely to have other health conditions like depression, post-traumatic stress disorder (PTSD), back pain and headache that may result in them reporting a lower quality of life.

6 Apr 2022

High-throughput screening assay could identify new prostate cancer drugs

A novel high-throughput screening assay is designed to identify inhibitors of the androgen receptor, which plays a critical role in the progression of prostate cancer.

6 Apr 2022

Insights into the pathophysiology of NeuroCOVID

A new study describes the neurological features of COVID-19, both short- and long-term.

6 Apr 2022

EMA issues qualification opinion for islet autoantibodies as enrichment biomarkers for T1D prevention trials

Critical Path Institute's Type 1 Diabetes Consortium (T1DC) today announced that the European Medicines Agency has issued a positive qualification opinion for pancreatic islet autoantibodies as enrichment biomarkers for type 1 diabetes (T1D) prevention trials.

5 Apr 2022

Difficult experiences in childhood influence vaccine resistance in adulthood

Curious about why some people have been so passionately, often angrily, opposed to vaccination against the COVID-19 virus, a team of researchers with access to rare and unusual insights into the childhood forces that shape our adult lives thought they'd try to find out.

5 Apr 2022

Losing sleep over the pandemic? Work flexibility may be a boon for night owls’ health

Many so-called night people feel that, when it comes to society's expectations about when the workday should start, they drew the short straw.

5 Apr 2022

Animal study provides insights into how COVID-19 can lead to long-term pain

A new animal study has provided important insights into how COVID-19 SARS-CoV-2 - the virus responsible for COVID-19 - can lead to long-term pain.

4 Apr 2022

Domestic violence survivor, UK patient stands and walks for the first time in more than eight years

"Deep breaths, April. Deep breaths." April Ballentine nods, steeling herself. As she sits inside the lab of the University of Kentucky's Sports Medicine Research Institute (SMRI), her anticipation stirs up an incredible amount of pure nervousness.

1 Apr 2022

Investigational new drug may be safe for patients with mild cognitive impairment, dementia

A small, preliminary study of an investigational new drug being studied for mild cognitive impairment and mild dementia associated with Alzheimer's disease suggests it is safe and may be associated with improvements in executive function, thinking and memory skills.

31 Mar 2022

Virginia Tech researcher awarded $1.9 million grant to study about mitophagy

Most of us remember enough biology to recall that mitochondria are known as "the powerhouse of the cell." Even that audacious term may downplay the importance of mitochondria and what happens when mitochondria go bad.

31 Mar 2022

GE-led team uses ultrasound to prevent or reverse Type-2 diabetes in preclinical models

Are we moving closer to the day when diabetes is no longer monitored and managed with blood sugar tests, insulin injections and drug treatments? A GE Research-led team, which includes The Feinstein Institutes for Medical Research, UCLA Samueli School of Engineering, Yale School of Medicine, and Albany Medical College, has demonstrated the ability to prevent or reverse the onset of diabetes in studies of three different preclinical model systems.

31 Mar 2022

Puerto Rican people with diabetes and high blood pressure show greater brain structural disruptions

The high rate of diabetes and high blood pressure combined in Puerto Rican people may be linked to structural changes in the brain, according to a study published in the March 30, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.

31 Mar 2022

Study shows weakened brain connections in young people at risk of bipolar disorder

A study that showed changes in the brain in those at risk of developing bipolar disorder raises new hope about early intervention.

30 Mar 2022

Caffeine could be a therapeutic arsenal to alleviate some of the ADHD symptoms

Attention Deficit Hyperactivity Disorder, or ADHD, is a psychiatric pathology for which diagnosis has increased exponentially over the last 20 years.

29 Mar 2022

New tissue-clearing method could speed the study of many disease-related biological processes

Scientists at Scripps Research have unveiled a new tissue-clearing method for rendering large biological samples transparent.

29 Mar 2022

$4 million program launched to find transformative therapies for ADNP syndrome

Researchers at the UC Davis MIND Institute are launching a $4 million program to find transformative therapies for ADNP syndrome. The rare genetic condition causes developmental delays and can affect the brain, heart, gastrointestinal system and more.

29 Mar 2022

Social media's influence on young people's wellbeing varies across adolescence

Girls and boys might be more vulnerable to the negative effects of social media use at different times during their adolescence, say an international team of scientists.

29 Mar 2022

Neuroscience News and Research

Certain antirheumatic drugs may lower incidence of Alzheimer's and related dementias in people with cardiovascular disease

Mutant mice with a human gene variant exhibits ADHD-like problems

Axol Bioscience Raises £3.2 Million GBP (c. $4.2 million USD)

People with some types of epilepsy may have a lower quality of life, study suggests

High-throughput screening assay could identify new prostate cancer drugs

Insights into the pathophysiology of NeuroCOVID

EMA issues qualification opinion for islet autoantibodies as enrichment biomarkers for T1D prevention trials

Difficult experiences in childhood influence vaccine resistance in adulthood

Losing sleep over the pandemic? Work flexibility may be a boon for night owls’ health

Animal study provides insights into how COVID-19 can lead to long-term pain

Domestic violence survivor, UK patient stands and walks for the first time in more than eight years

Investigational new drug may be safe for patients with mild cognitive impairment, dementia

Virginia Tech researcher awarded $1.9 million grant to study about mitophagy

GE-led team uses ultrasound to prevent or reverse Type-2 diabetes in preclinical models

Puerto Rican people with diabetes and high blood pressure show greater brain structural disruptions

Study shows weakened brain connections in young people at risk of bipolar disorder

Caffeine could be a therapeutic arsenal to alleviate some of the ADHD symptoms

New tissue-clearing method could speed the study of many disease-related biological processes

$4 million program launched to find transformative therapies for ADNP syndrome

Social media's influence on young people's wellbeing varies across adolescence

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News